Clinical Trials – US

Clinical Trials – US

Studies on the safety and efficacy of SVF in the most recent USA clinical trials (animal and human Phase 1 & II trials) provide insight and knowledge into a growing body of research for various, chronic medical conditions.

Applications – OUS

Applications OUS

The Icellator® has already been approved for commercial use in Korea as a Class III medical device by the Korean FDA (KMFDS) and has been used in more than 1,200 commercial applications. The Ukraine and The Bahamas have also given regulatory approval for Tissue Genesis’ patented, clinical grade cell therapy processing solutions. In 2017, Human Life CORD, Japan struck a 10-year exclusive agreement with TG to distribute its products in commercial clinics, research institutions, and hospitals in Japan and China.

Distributors

Distributors

In addition to direct sales and support, we partner with a network of distributors to reach and service customers across the globe. For a list of current distributors, click here.